22Indexed trials
mesh condition
Glioma
Intelligence
Glioma intelligence: 22 indexed trials, 5 recruiting studies, 18 sponsors across 11 countries.
5Recruiting
18Sponsors
11Countries
Leading sponsors
Beijing Neurosurgical Institute20 recruiting
Annick Desjardins20 recruiting
Duke University20 recruiting
University of Texas Southwestern Medical Center20 recruiting
DelMar Pharmaceuticals, Inc.10 recruiting
Eli Lilly and Company10 recruiting
Alliance for Clinical Trials in Oncology11 recruiting
INSYS Therapeutics Inc10 recruiting
Jose Carrillo10 recruiting
Leiden University Medical Center11 recruiting
Mayo Clinic11 recruiting
National Cancer Institute (NCI)10 recruiting
Geographic activity
United States15trials
Netherlands5trials
Germany2trials
Canada2trials
China2trials
United Kingdom1trials
France1trials
Belgium1trials
Colombia1trials
Austria1trials
Israel1trials
Leading interventions
Levetiracetam2trials
7 Tesla Scanning1trials
Carboplatin1trials
Abemaciclib1trials
Bevacizumab1trials
CCNU1trials
AZD74511trials
Cerebral open flow microperfusion1trials
Dexamethasone1trials
Enzastaurin (LY317615)1trials
Fluorescence-Guided Surgery1trials
3 Tesla scanning1trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.